La TFDA homologue NaoTrac, le premier robot de navigation neurochirurgicale autonome de Brain Navi Biotechnology ...Middle East

HSINCHU, 8 août 2022 /PRNewswire/ -- NaoTrac, le robot de navigation neurochirurgical certifié CE, a obtenu l'approbation de la Taiwan's Food and Drug Administration (TFDA) en juillet 2022, et sa soumission à la FDA (U.S. Food and Drug Administration) pour autorisation est prévue pour la...

Hence then, the article about la tfda homologue naotrac le premier robot de navigation neurochirurgicale autonome de brain navi biotechnology was published today ( Monday 08/08/2022 - 03:04 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( La TFDA homologue NaoTrac, le premier robot de navigation neurochirurgicale autonome de Brain Navi Biotechnology )

Also on site :

• Annum Capital and Turoid - Unlocking AI for Asia Family Offices
• Best VPN (January 2026): Webroot Named Top Secure Browsing and Privacy Tool by Software Experts
• Calling All STEM Students: Apply for PG&E College Scholarships of Up to $10,000